Singapore, March 9, 2007: Philadelphia-based medical technology company, Biofield has received a major order from a leading hospital in Philippines.

As per the deal, the company will supply Biofield Diagnostic System and three cases of sensors which can be used for nearly 600 exams.

Biofield Diagnostic System, a breast cancer diagnostic device, which employs single-use sensors to measure and analyze changes in cellular electrical charge distributions associated with the development of epithelial cancers, such as breast, ovaries, skin, prostate and colon cancers.

Biofield believes that there are great opportunities for its technology in the Philippines, which has 27 million women ages 15-64 years old.

Mr James MacKay, Biofield’s Chairman, said, “I am particularly gratified to know that the hospital plans to utilize one of the key features of our unit, its mobility. In April, they will start to take the unit to the provinces as part of their mobile health systems services."